{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:07:21Z","timestamp":1768788441875,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11936-015-0388-8","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:41:07Z","timestamp":1431304867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of Advanced Heart Failure due to Cancer Therapy: the Present Role of Mechanical Circulatory Support and Cardiac Transplantation"],"prefix":"10.1007","volume":"17","author":[{"given":"Salil V.","family":"Deo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadeer G.","family":"Al-Kindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme H.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"issue":"20","key":"388_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","volume":"345","author":"EA Rose","year":"2001","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435\u201343.","journal-title":"N Engl J Med"},{"issue":"8","key":"388_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.healun.2012.03.018","volume":"31","author":"GH Oliveira","year":"2012","unstructured":"Oliveira GH, Hardaway BW, Kucheryavaya AY, Stehlik J, Edwards LB, Taylor DO. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant : Off Pub Int Soc Heart Transplant. 2012;31(8):805\u201310. This article presents retrospective analysis of a prospective large database outlining the results of heart transplantation in patients with chemotherapy induced heart failure.","journal-title":"J Heart Lung Transplant : Off Pub Int Soc Heart Transplant"},{"issue":"3","key":"388_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jacc.2013.09.040","volume":"63","author":"GH Oliveira","year":"2014","unstructured":"Oliveira GH, Dupont M, Naftel D, Myers SL, Yuan Y, Tang WH, et al. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the intermacs registry (interagency registry for mechanically assisted circulatory support). J Am Coll Cardiol. 2014;63(3):240\u20138. This is a retrospective review of the INTERMACS database, a prospectively collected national registry of patients undergoing mechanical circulatory support surgery in the USA. The article looks at pre-operative differences, early results, and late survival in CCMP patients undergoing LVAD implant.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"388_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCHEARTFAILURE.114.001292","volume":"7","author":"GH Oliveira","year":"2014","unstructured":"Oliveira GH, Qattan MY, Al-Kindi S, Park SJ. Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy. Circ Heart fail. 2014;7(6):1050\u20138.","journal-title":"Circ Heart fail"},{"issue":"5","key":"388_CR5","first-page":"277","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: Cancer J Clin. 2010;60(5):277\u2013300.","journal-title":"CA: Cancer J Clin"},{"issue":"1","key":"388_CR6","first-page":"9","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J Clin. 2014;64(1):9\u201329.","journal-title":"CA: Cancer J Clin"},{"issue":"25","key":"388_CR7","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109(25):3122\u201331.","journal-title":"Circulation"},{"key":"388_CR8","doi-asserted-by":"crossref","unstructured":"Yu AF, Steingart RM, Fuster V: Cardiomyopathy associated with cancer therapy. Journal of cardiac failure (2014). This review presents the mechanism and etio-pathogenesis of heart failure in chemotherapy patients.","DOI":"10.1016\/j.cardfail.2014.08.004"},{"issue":"1","key":"388_CR9","doi-asserted-by":"publisher","first-page":"e000472","DOI":"10.1161\/JAHA.113.000472","volume":"3","author":"G Ezaz","year":"2014","unstructured":"Ezaz G, Long JB, Gross CP, Chen J. Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc. 2014;3(1):e000472.","journal-title":"J Am Heart Assoc"},{"key":"388_CR10","doi-asserted-by":"crossref","unstructured":"Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, Border WL, Feijen EA, Green DM, Meacham LR, Meeske KA et al.: Individual prediction of heart failure among childhood cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014).","DOI":"10.1200\/JCO.2014.56.1373"},{"issue":"11","key":"388_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18(11):1639\u201342.","journal-title":"Nat Med"},{"issue":"14","key":"388_CR12","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.113.005395","volume":"128","author":"LT Cooper Jr","year":"2013","unstructured":"Cooper Jr LT. Role of left ventricular biopsy in the management of heart disease. Circulation. 2013;128(14):1492\u20134.","journal-title":"Circulation"},{"issue":"31","key":"388_CR13","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","volume":"23","author":"MS Ewer","year":"2005","unstructured":"Ewer MS, Vooletich MT, Durand JB, Woods ML, Davis JR, Valero V, et al. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol : Off J Am Soc Clin Oncol. 2005;23(31):7820\u20136.","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"23","key":"388_CR14","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","volume":"25","author":"ML Telli","year":"2007","unstructured":"Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol. 2007;25(23):3525\u201333.","journal-title":"J Clin Oncol"},{"issue":"10","key":"388_CR15","doi-asserted-by":"publisher","first-page":"12268","DOI":"10.3390\/ijms131012268","volume":"13","author":"AS Hervent","year":"2012","unstructured":"Hervent AS, De Keulenaer GW. Molecular mechanisms of cardiotoxicity induced by erbb receptor inhibitor cancer therapeutics. Int J Mol Sci. 2012;13(10):12268\u201386.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"388_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/ctrv.1999.0128","volume":"25","author":"MT Meinardi","year":"1999","unstructured":"Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev. 1999;25(4):237\u201347.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"388_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","volume":"125","author":"K Shan","year":"1996","unstructured":"Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996;125(1):47\u201358.","journal-title":"Ann Intern Med"},{"issue":"4","key":"388_CR18","first-page":"554","volume":"39","author":"N Khan","year":"2012","unstructured":"Khan N, Husain SA, Husain SI, Khalaf N, George J, Raissi F, et al. Remission of chronic anthracycline-induced heart failure with support from a continuous-flow left ventricular assist device. Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp, Texas Child Hosp. 2012;39(4):554\u20136.","journal-title":"Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp, Texas Child Hosp"},{"issue":"11","key":"388_CR19","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.amjcard.2014.03.018","volume":"113","author":"GH Oliveira","year":"2014","unstructured":"Oliveira GH, Mukerji S, Hernandez AV, Qattan MY, Banchs J, Durand JB, et al. Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients. Am J Cardiol. 2014;113(11):1893\u20138. This is a retrospective chart review of patients from a tertiary-level cancer center. The article presents data on patients who developed left ventricular dysfunction while on chemotherapy.","journal-title":"Am J Cardiol"},{"issue":"5","key":"388_CR20","first-page":"827","volume":"63","author":"C Praga","year":"1979","unstructured":"Praga C, Beretta G, Vigo PL, Lenaz GR, Pollini C, Bonadonna G, et al. Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treat Rep. 1979;63(5):827\u201334.","journal-title":"Cancer Treat Rep"},{"issue":"24","key":"388_CR21","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","volume":"60","author":"J Chen","year":"2012","unstructured":"Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol. 2012;60(24):2504\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"388_CR22","doi-asserted-by":"crossref","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH: Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy\u2014a systematic review. Journal of the American College of Cardiology (2014)","DOI":"10.1016\/j.jacc.2014.01.073"},{"issue":"11","key":"388_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12170-014-0406-5","volume":"8","author":"S Al-Kindi","year":"2014","unstructured":"Al-Kindi S, Younes A, Qattan M, Oliveira G. Preemptive cardioprotective strategies in patients receiving chemotherapy. Curr Cardiovasc Risk Rep. 2014;8(11):1\u201314.","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"13","key":"388_CR24","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","volume":"49","author":"K Kalam","year":"2013","unstructured":"Kalam K, Marwick TH. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. Eur J Cancer. 2013;49(13):2900\u20139.","journal-title":"Eur J Cancer"},{"issue":"23","key":"388_CR25","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"X Bosch","year":"2013","unstructured":"Bosch X, Rovira M, Sitges M, Domenech A, Ortiz-Perez JT, de Caralt TM, et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the overcome trial (prevention of left ventricular dysfunction with enalapril and carvedilol in patients submitted to intensive chemotherapy for the treatment of malignant hemopathies). J Am Coll Cardiol. 2013;61(23):2355\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"388_CR26","first-page":"246","volume":"38","author":"ET Yeh","year":"2011","unstructured":"Yeh ET. Onco-cardiology: the time has come. Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp Texas Child Hosp. 2011;38(3):246\u20137.","journal-title":"Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp Texas Child Hosp"},{"issue":"4","key":"388_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.amjcard.2009.10.024","volume":"105","author":"J Rickard","year":"2010","unstructured":"Rickard J, Kumbhani DJ, Baranowski B, Martin DO, Tang WH, Wilkoff BL. Usefulness of cardiac resynchronization therapy in patients with adriamycin-induced cardiomyopathy. Am J Cardiol. 2010;105(4):522\u20136.","journal-title":"Am J Cardiol"},{"issue":"16","key":"388_CR28","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation. 2013;128(16):e240\u2013327.","journal-title":"Circulation"},{"issue":"14","key":"388_CR29","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/CIRCULATIONAHA.110.982512","volume":"123","author":"GC Stewart","year":"2011","unstructured":"Stewart GC, Stevenson LW. Keeping left ventricular assist device acceleration on track. Circulation. 2011;123(14):1559\u201368.","journal-title":"Circulation"},{"issue":"6","key":"388_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","volume":"33","author":"JK Kirklin","year":"2014","unstructured":"Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth intermacs annual report: a 10,000-patient database. J Heart Lung Transplant : Off Pub Int Soc Heart Transplant. 2014;33(6):555\u201364. This study reports the overall results of LVAD and TAH implant in the United States.","journal-title":"J Heart Lung Transplant : Off Pub Int Soc Heart Transplant"},{"issue":"19","key":"388_CR31","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","volume":"116","author":"LT Cooper","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116(19):2216\u201333.","journal-title":"Circulation"},{"issue":"3","key":"388_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10047-011-0567-7","volume":"14","author":"C Kurihara","year":"2011","unstructured":"Kurihara C, Nishimura T, Nawata K, Kinoshita O, Hisagi M, Motomura N, et al. Successful bridge to recovery with vad implantation for anthracycline-induced cardiomyopathy. J Artif Organs : Off J Jpn Soc Artif Organs. 2011;14(3):249\u201352.","journal-title":"J Artif Organs : Off J Jpn Soc Artif Organs"},{"issue":"1","key":"388_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.healun.2008.10.002","volume":"28","author":"M Freilich","year":"2009","unstructured":"Freilich M, Stub D, Esmore D, Negri J, Salamonsen R, Bergin P, et al. Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant : Off Pub Int Soc Heart Transplant. 2009;28(1):101\u20133.","journal-title":"J Heart Lung Transplant : Off Pub Int Soc Heart Transplant"},{"issue":"3","key":"388_CR34","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1542\/peds.2013-2272","volume":"134","author":"A Cavigelli-Brunner","year":"2014","unstructured":"Cavigelli-Brunner A, Schweiger M, Knirsch W, Stiasny B, Klingel K, Kretschmar O, et al. Vad as bridge to recovery in anthracycline-induced cardiomyopathy and hhv6 myocarditis. Pediatrics. 2014;134(3):e894\u20139.","journal-title":"Pediatrics"},{"key":"388_CR35","unstructured":"http:\/\/www.abiomed.com"},{"issue":"5","key":"388_CR36","first-page":"587","volume":"40","author":"JG Copeland","year":"2013","unstructured":"Copeland JG. Syncardia total artificial heart: update and future. Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp Texas Child Hosp. 2013;40(5):587\u20138.","journal-title":"Texas Heart Inst J \/ Texas Heart Inst St Luke\u2019s Episcopal Hosp Texas Child Hosp"},{"key":"388_CR37","doi-asserted-by":"crossref","unstructured":"Hayashi T, Inagaki H, Kimura S, Higuchi K, Kawabata M, Haraguchi G, Hachiya H, Hirao K, Isobe M: A case of adriamycin-induced cardiomyopathy implanted artificial heart after having the uncontrollable arrhythmia. Journal of cardiac failure 16(9):S147","DOI":"10.1016\/j.cardfail.2010.07.082"},{"issue":"8","key":"388_CR38","first-page":"1120","volume":"6","author":"MC Alraies","year":"2014","unstructured":"Alraies MC, Eckman P. Adult heart transplant: indications and outcomes. J Thorac Dis. 2014;6(8):1120\u20138.","journal-title":"J Thorac Dis"},{"issue":"20","key":"388_CR39","first-page":"1353","volume":"319","author":"M Arico","year":"1988","unstructured":"Arico M, Nespoli L, Pedroni E, Bonetti F, Vigano M, Burgio GR. Heart transplantation in a child with doxorubicin-induced cardiomyopathy. N Engl J Med. 1988;319(20):1353.","journal-title":"N Engl J Med"},{"issue":"8","key":"388_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/adc.66.8.985","volume":"66","author":"M Arico","year":"1991","unstructured":"Arico M, Pedroni E, Nespoli L, Vigano M, Porta F, Burgio GR. Long term survival after heart transplantation for doxorubicin induced cardiomyopathy. Arch Dis Child. 1991;66(8):985\u20136.","journal-title":"Arch Dis Child"},{"issue":"4","key":"388_CR41","first-page":"309","volume":"7","author":"M Goenen","year":"1988","unstructured":"Goenen M, Baele P, Lintermans J, Lecomte C, Col J, Ponlot R, et al. Orthotopic heart transplantation eleven years after left pneumonectomy. J Heart Transplant. 1988;7(4):309\u201311.","journal-title":"J Heart Transplant"},{"issue":"2","key":"388_CR42","first-page":"66","volume":"2","author":"KL Grady","year":"1987","unstructured":"Grady KL, Jassak PF, Varricchio CG. Cardiac transplantation for doxorubicin cardiotoxicity. Prog Cardiovasc Nurs. 1987;2(2):66\u201370.","journal-title":"Prog Cardiovasc Nurs"},{"issue":"9","key":"388_CR43","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.healun.2003.08.014","volume":"23","author":"KM Ward","year":"2004","unstructured":"Ward KM, Binns H, Chin C, Webber SA, Canter CE, Pahl E. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant : Off Pub Int Soc Heart Transplant. 2004;23(9):1040\u20135.","journal-title":"J Heart Lung Transplant : Off Pub Int Soc Heart Transplant"},{"issue":"4","key":"388_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.amjcard.2012.10.048","volume":"111","author":"AJ Lenneman","year":"2013","unstructured":"Lenneman AJ, Wang L, Wigger M, Frangoul H, Harrell FE, Silverstein C, et al. Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy. Am J Cardiol. 2013;111(4):609\u201312.","journal-title":"Am J Cardiol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-015-0388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11936-015-0388-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-015-0388-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-015-0388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:40:36Z","timestamp":1744173636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11936-015-0388-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s11936-015-0388-8","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]},"assertion":[{"value":"12 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}